The Effects of the Novel Unloading Device "HEPHAISTOS" on Bone, Muscles and Vessels (HEP)

March 15, 2017 updated by: DLR German Aerospace Center

The Effects of a 56day Unilateral Muscular Unloading Intervention With a Novel Device That Allows Normal Ambulation While Reducing Muscle Activation Drastically, on Muscles, Bones and Vessels

11 healthy men used the HEPHAISTOS unloading orthosis in an ambulatory 8 week intervention study.

It greatly reduces calf muscle forces without reducing ground reaction forces.

Study Overview

Status

Completed

Detailed Description

The 56day unloading intervention with HEPHAISTOS had the following key objectives:

  1. Primary objective: Assessment and evaluation of bone adaptation.
  2. Secondary objective: Assessment and evaluation of functional and structural muscular adaptations.
  3. Third objective: Assessment and evaluation of functional and structural vascular adaptations.
  4. Fourth objective: Assessment and evaluation if the present findings deviate from findings observed in established unloading models.

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Rine Westphalia
      • Cologne, North Rine Westphalia, Germany, 51147
        • German Aerospace Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • male
  • age: 20-45
  • BMI: 20-30

Exclusion Criteria:

  • smoking
  • professional sports men
  • diabetes
  • rheumatism
  • muscle and joint disease
  • bone fractures within 12 months prior to the study
  • cruciate ligament rupture within 10 years prior to the study
  • metal implants
  • participation in any other clinical study within 2 months prior to the study haemophilia
  • any blood vessel disease
  • epilepsy
  • claustrophobia
  • herniated disk
  • cardiac pulse generator
  • drug or alcohol abuse
  • hyperlipidaemia
  • kidney disease
  • hyperhomocysteaemia
  • hyper/hypouricemia
  • hyper/hypocalcaemia
  • anaemia
  • vitamin d deficit
  • chronical back pain
  • deficient certificate of good conduct
  • achilles tendon injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Hephaistos unloading orthosis
Hephaistos unloading orthosis: Calf muscle unloading: The 11 male subjects had to wear a novel orthosis for 8 weeks, which greatly reduces plantarflexor forces during gait.
The Hephaistos unloading orthosis greatly reduces plantarflexor muscle torque and plantarflexor muscle activation during any gait activity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone density as measured with pQCT
Time Frame: At baseline and up to 12 months after the immobilization phase
Change from baseline to 14 days after immobilization phase
At baseline and up to 12 months after the immobilization phase

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Structural and functional parameters of arterial adaptation
Time Frame: At baseline and up to 12 months after the immobilization phase
Change in intima & media thickness.
At baseline and up to 12 months after the immobilization phase
Structural and functional parameters of arterial adaptation
Time Frame: At baseline and up to 12 months after the immobilization phase
Change in arterial diameter
At baseline and up to 12 months after the immobilization phase
Structural and functional parameters of arterial adaptation
Time Frame: At baseline and up to 12 months after the immobilization phase
Change in blood flow
At baseline and up to 12 months after the immobilization phase
Structural and functional parameters of arterial adaptation
Time Frame: At baseline and up to 12 months after the immobilization phase
Change in flow-mediated dilation
At baseline and up to 12 months after the immobilization phase

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jörn Rittweger, Prof. Dr., German Aerospace Center (DLR)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

August 1, 2011

Study Completion (Actual)

July 1, 2012

Study Registration Dates

First Submitted

July 31, 2012

First Submitted That Met QC Criteria

March 15, 2017

First Posted (Actual)

March 22, 2017

Study Record Updates

Last Update Posted (Actual)

March 22, 2017

Last Update Submitted That Met QC Criteria

March 15, 2017

Last Verified

March 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle; Atrophy, General

Clinical Trials on Hephaistos unloading orthosis

Subscribe